Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine

[1] Jemal A(2007)Cancer Statistics 2007 CA Cancer J Clin 57 43-66

[2] Siegal R(1999)Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy J Clin Oncol 17 1760-1970

[3] Ward E(1999)Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil Clin Cancer Res 5 1996-9

[4] Murray T(1999)Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine Clin Cancer Res 5 325-328

[5] Xu J-Q(2002)Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer Eur J Cancer 38 527-534

[6] Thun MJ(2003)Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer J Clin Oncol 21 406-412

[7] Aschele C(1997)Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin J Clin Oncol 15 3223-3229

[8] Debernardis D(2003)Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed Clin Cancer Res 9 792-801

[9] Casazza S(2001)ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy J Clin Oncol 19 4298-4304

[10] Antonelli G(2002)Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses J Clin Oncol 20 2832-2843

[1] Jemal A(2007)Cancer Statistics 2007 CA Cancer J Clin 57 43-66

[2] Siegal R(1999)Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy J Clin Oncol 17 1760-1970

[3] Ward E(1999)Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil Clin Cancer Res 5 1996-9

[4] Murray T(1999)Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine Clin Cancer Res 5 325-328

[5] Xu J-Q(2002)Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer Eur J Cancer 38 527-534

[6] Thun MJ(2003)Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer J Clin Oncol 21 406-412

[7] Aschele C(1997)Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin J Clin Oncol 15 3223-3229

[8] Debernardis D(2003)Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed Clin Cancer Res 9 792-801

[9] Casazza S(2001)ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy J Clin Oncol 19 4298-4304

[10] Antonelli G(2002)Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses J Clin Oncol 20 2832-2843